These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 35013064)

  • 1. Time series proteome profile analysis reveals a protective role of citrate synthase in angiotensin II-induced atrial fibrillation.
    Teng F; Han X; Yu P; Li PB; Li HH; Zhang YL
    J Hypertens; 2022 Apr; 40(4):765-775. PubMed ID: 35013064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Costunolide ameliorates angiotensin II-induced atrial inflammation and fibrosis by regulating mitochondrial function and oxidative stress in mice: A possible therapeutic approach for atrial fibrillation.
    Liu Y; Wang D; Jin Y; Sun G; Lou Q; Wang H; Li W
    Microvasc Res; 2024 Jan; 151():104600. PubMed ID: 37666318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endothelial nitric oxide synthase-independent protective action of statin against angiotensin II-induced atrial remodeling via reduced oxidant injury.
    Yagi S; Akaike M; Aihara K; Ishikawa K; Iwase T; Ikeda Y; Soeki T; Yoshida S; Sumitomo-Ueda Y; Matsumoto T; Sata M
    Hypertension; 2010 Apr; 55(4):918-23. PubMed ID: 20194307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel Role for the Immunoproteasome Subunit PSMB10 in Angiotensin II-Induced Atrial Fibrillation in Mice.
    Li J; Wang S; Bai J; Yang XL; Zhang YL; Che YL; Li HH; Yang YZ
    Hypertension; 2018 May; 71(5):866-876. PubMed ID: 29507100
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Xu B; Xu Y; Ren W; Meng S; Hong T; Cao Z; Xiao X; Guo X; Yu L; Zhao J; Wang H
    Food Funct; 2024 Sep; 15(18):9165-9175. PubMed ID: 39157962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NPR-C (Natriuretic Peptide Receptor-C) Modulates the Progression of Angiotensin II-Mediated Atrial Fibrillation and Atrial Remodeling in Mice.
    Jansen HJ; Mackasey M; Moghtadaei M; Liu Y; Kaur J; Egom EE; Tuomi JM; Rafferty SA; Kirkby AW; Rose RA
    Circ Arrhythm Electrophysiol; 2019 Jan; 12(1):e006863. PubMed ID: 30636477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Time Series Gene Expression Profiling and Temporal Regulatory Pathway Analysis of Angiotensin II Induced Atrial Fibrillation in Mice.
    Wu YX; Han X; Chen C; Zou LX; Dong ZC; Zhang YL; Li HH
    Front Physiol; 2019; 10():597. PubMed ID: 31191333
    [No Abstract]   [Full Text] [Related]  

  • 8. Immunoproteasome Subunit β5i Promotes Ang II (Angiotensin II)-Induced Atrial Fibrillation by Targeting ATRAP (Ang II Type I Receptor-Associated Protein) Degradation in Mice.
    Li J; Wang S; Zhang YL; Bai J; Lin QY; Liu RS; Yu XH; Li HH
    Hypertension; 2019 Jan; 73(1):92-101. PubMed ID: 30571551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of UCHL1 by LDN-57444 attenuates Ang II-Induced atrial fibrillation in mice.
    Bi HL; Zhang YL; Yang J; Shu Q; Yang XL; Yan X; Chen C; Li Z; Li HH
    Hypertens Res; 2020 Mar; 43(3):168-177. PubMed ID: 31700166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adipose Triglyceride Lipase Deficiency Aggravates Angiotensin II-Induced Atrial Fibrillation by Reducing Peroxisome Proliferator-Activated Receptor α Activation in Mice.
    Han X; Zhang YL; Zhao YX; Guo SB; Yin WP; Li HH
    Lab Invest; 2023 Jan; 103(1):100004. PubMed ID: 36748188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemokine Receptor CXCR-2 Initiates Atrial Fibrillation by Triggering Monocyte Mobilization in Mice.
    Zhang YL; Cao HJ; Han X; Teng F; Chen C; Yang J; Yan X; Li PB; Liu Y; Xia YL; Guo SB; Li HH
    Hypertension; 2020 Aug; 76(2):381-392. PubMed ID: 32639881
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Melatonin inhibits angiotensin II-induced atrial fibrillation through preventing degradation of Ang II Type I Receptor-Associated Protein (ATRAP).
    Xie X; Shen TT; Bi HL; Su ZL; Liao ZQ; Zhang Y; Shi L; Xia YL
    Biochem Pharmacol; 2022 Aug; 202():115146. PubMed ID: 35710020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LOXL2 Inhibitor Attenuates Angiotensin II-Induced Atrial Fibrosis and Vulnerability to Atrial Fibrillation through Inhibition of Transforming Growth Factor Beta-1 Smad2/3 Pathway.
    Wu Y; Can J; Hao S; Qiang X; Ning Z
    Cerebrovasc Dis; 2022; 51(2):188-198. PubMed ID: 34515064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of Genes Related to Angiotensin II-Induced Arterial Injury Using a Time Series Microarray.
    Zhang YL; Zhi LY; Zou LX; Chen C; Bai J; Lin QY; Lai S; Wang L; Liu Y; Li HH
    Cell Physiol Biochem; 2018; 48(3):983-992. PubMed ID: 30036880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distinct patterns of atrial electrical and structural remodeling in angiotensin II mediated atrial fibrillation.
    Jansen HJ; Mackasey M; Moghtadaei M; Belke DD; Egom EE; Tuomi JM; Rafferty SA; Kirkby AW; Rose RA
    J Mol Cell Cardiol; 2018 Nov; 124():12-25. PubMed ID: 30273558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelets Promote Ang II (Angiotensin II)-Induced Atrial Fibrillation by Releasing TGF-β1 (Transforming Growth Factor-β1) and Interacting With Fibroblasts.
    Liu Y; Lv H; Tan R; An X; Niu XH; Liu YJ; Yang X; Yin X; Xia YL
    Hypertension; 2020 Dec; 76(6):1856-1867. PubMed ID: 33175633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PU.1 inhibition attenuates atrial fibrosis and atrial fibrillation vulnerability induced by angiotensin-II by reducing TGF-β1/Smads pathway activation.
    Hu J; Zhang JJ; Li L; Wang SL; Yang HT; Fan XW; Zhang LM; Hu GL; Fu HX; Song WF; Yan LJ; Liu JJ; Wu JT; Kong B
    J Cell Mol Med; 2021 Jul; 25(14):6746-6759. PubMed ID: 34132026
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiotensin II antagonist prevents electrical remodeling in atrial fibrillation.
    Nakashima H; Kumagai K; Urata H; Gondo N; Ideishi M; Arakawa K
    Circulation; 2000 Jun; 101(22):2612-7. PubMed ID: 10840013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pitavastatin, an HMG-CoA reductase inhibitor, exerts eNOS-independent protective actions against angiotensin II induced cardiovascular remodeling and renal insufficiency.
    Yagi S; Aihara K; Ikeda Y; Sumitomo Y; Yoshida S; Ise T; Iwase T; Ishikawa K; Azuma H; Akaike M; Matsumoto T
    Circ Res; 2008 Jan; 102(1):68-76. PubMed ID: 17967781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MFAP4 deletion attenuates the progression of angiotensin II-induced atrial fibrosis and atrial fibrillation.
    Wang H; Liu M; Wang X; Shuai W; Fu H
    Europace; 2022 Feb; 24(2):340-347. PubMed ID: 34379753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.